Clinical Trials Research
Ausio Pharmaceuticals ER(beta) Agonist AUS-131 is Well Tolerated in First Human Clinical Trials
Published in Women's Health Weekly, April 7th, 2011
2011 APR 7 -- Results of two Phase 1 clinical trials of S-equol (AUS-131) were published in the February issue of Menopause: The Journal of the North American Menopause Society. This first-in-class, nonsteroidal, nonhormonal estrogen receptor (beta) (ER(beta)) agonist offers a potentially safer alternative to estrogen for the treatment of menopausal symptoms. As part of a drug development program, these studies were the first to investigate AUS-131 in humans. Results demonstrated a favorable safety and pharmacokinetic profile for AUS-131, and have allowed the company to proceed to Phase 2 clinical trials, which will be completed in Q3 2011.
These studies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Data from City of Hope National Medical Center Provide New Insights into Breast Cancer - Breast Cancer
Data on Breast Cancer Described by Researchers at Boston University - Menopause
Data on Menopause Published by Researchers at University of Queensland - Osteoporosis
Data on Osteoporosis Discussed by Researchers at College of Medicine - Genetics and Breast Cancer
Findings from Boston University in Genetics and Breast Cancer Reported - Osteoporosis
Findings from University of Sheffield Provide New Insights into Osteoporosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
